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Objective: As intermittent claudication (IC) infrequently progresses to limb loss many clinicians adopt a conservative 
approach to treatment. Recently percutaneous transluminaI angioplasty (PTA) has been applied to patients with IC. If this 
were to become the first line treatment for IC it would have major implications in terms of hospital facilities as well as cost. 
A measure is required, therefore, to decide on rationing of limited financial resources. "Quality of life" may be more 
influential in determining demand on services ince objective medical criteria cannot give an insight into the patients 
feelings of well being. 
Design: We applied the Nottingham Health Profile, by post, to a group of claudicants and age~sex matched controls. 70% 
responded from both groups. Claudicants who had recently received intervention were excluded, as were controls 
complaining of any leg pains on walking. 
Results: The results showed that claudicants have greater perceived problems in the areas of energy, pain, emotional 
reactions, sleep, and physical mobility compared to controls (p < 0.05; Mann-Whitney Test). This was reflected by a 
significantly greater positive response rate to problems with activities of daily living (0.05 > p > 0.02; Chi-square Test) in 
the claudicant group. 
Conclusion: Because of the cost and resource implications of introducing measures such as PTA to the treatment of vast 
numbers of patients with IC, we suggest hat trials are needed to compare various treatments using quality of life 
measurements in addition to traditional efficaey/safety parameters. 
Introduction 
Intermittent claudication (IC) is the commonest mani- 
festation of peripheral vascular disease, affecting more 
than 5% of men over the age of 50 years. 1 Recon- 
structive surgery has not been widely applied to 
patients with intermittent claudication because the 
discomfort and restriction in lifestyle are not con- 
sidered, by clinicians, severe enough to justify the 
surgical risks. 2 Treatment for IC has, therefore, been 
largely conservative. Recently there has been con- 
troversy about the role percutaneous transluminal 
angioplasty (PTA) has to play in the treatment of 
patients with mild IC 3-7 as up to 40% of patients with 
IC have arterial lesions amenable to angioplasty. These 
reports have concentrated on technical success, 
improvements in ankle-brachial pressure index, and 
patency rates for evaluating outcome. It has been 
suggested that the beneficial effect on increased 
quality of life should be considered in deciding which 
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treatment modality is best. s Claudication is a sub- 
jective phenomenon and therefore the impact it has on 
life can only be perceived by the patient. Also 
improvement, if any, after therapy can only be 
assessed by the patient - -  hence the need for 
objective evaluation of the patient's quality of life 
before and after intervention. 
Qualify of life encompasses many aspects of an 
individual's life incorporating socioeconomic factors, 
housing, interpersonal relationships, and job satisfac- 
tion. 9 Studies have shown disparity in clinicians' and 
patients' judgements of quality of life. 1°'11 A review of 
the literature revealed only two studies looking at 
quality of life in patients with peripheral vascular 
disease. 1233 Hunt et al. 12 did not look specifically at 
patients with IC. Arfvidsson et al. 13 studied claudi- 
cants and linked quality of life with mobility, however 
the controls used in this study comprised an historical 
group of women only. 
We, therefore, looked at the quality of life using the 
Nottingham Health Profile (NHP) ~4 in a group of 
patients with intermittent claudication to assess the 
actual degree of the problem compared to age and sex 
matched controls. 
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Methods 
Ethics Committee approval was obtained for this 
study. One hundred questionnaires were sent with a 
covering letter to patients with IC on a register kept by 
the department. All of these patients had been fully 
investigated and diagnosed as having IC based on 
ankle-brachial pressure indices less than 0.8 and a 
decrease in ankle pressures of > 30mmHg after exer- 
cise. A covering letter explained the purpose of the 
questionnaire and requested the patients to complete 
and return it in the enclosed reply-paid envelope. In 
addition to the NHP, the patients were asked about 
other illnesses and about any treatment they may have 
had. One hundred age and sex matched controls, with 
minor non-debilitating surgical problems such as 
herniae and varicose veins, were chosen from a 
waiting list and sent the questionnaire with similar 
instructions. No attempt was made to contact non- 
responders. 
The NHP consists of two parts. Section I assesses 
perceived health problems in the areas of sleep, 
energy, emotional reactions, social isolation, physical 
mobilit)~ and pain. Section I comprises 38 questions, 
each with a yes/no response, which provide weighted 
scores 15 for the areas mentioned. Section II assesses 
the extent o which such problems affect daily activ- 
ities, such as occupation, hobbies, holidays etc. The 
NHP has been well validated as a self-administered 
questionnaire. 14 
Differences between the two groups were assessed 
using the Mann-Whitney test for section I of the NHP 
and the Chi-square test for section II. Correlations 
between the various factors in section I were assessed 
using Spearman's Rank Correlation Test. A value of 
p < 0.05 was taken as statistically significant. 
Results 
The response rate was 68% for claudicants and 72% for 
controls. Nine controls complained of leg pains and 
were therefore xcluded. Of the claudicant group, five 
had had recent treatment and three returned incom- 
plete questionnaires - - these were also excluded. The 
demographic data for the remaining patients in both 
groups is shown in Table 1. 
Patients with IC had significantly worse mean 
scores in the areas of energy, pain, emotional reactions, 
sleep, and physical mobility than controls (Fig. 1). 
There was no difference between the two groups for 
feelings of social isolation (such as "I feel lonely" and 
"I feel there is nobody I am close to"). 
Table 1. Demographic data for the claudicant and control groups 
showing good age and sex matching 
Claudicants Controls 
n 60 63 
Median age (range) years 66 (43-84) 64 (29-78) p=0.1* 
Male : female 43:17 43:20 p>0.5 ~
• * Mann-Whitney Test. 
Chi-square Test. 
Table 2 shows the correlation coefficients for the 
components of section I for claudicants, demonstrat- 
ing statistically significant correlations (Spearman's 
Rank Correlation Test). Logistic regression analysis 
was used to determine which of the six areas of section 
I were significant in predicting cases and controls. A 
stepwise limination procedure was used and showed 
that physical mobility was the only factor with a 
significant predictive ffect (Score statistic for test: chi- 
square = 8.714, DF = 1, p = 0.003). 
The percentage positive responses for areas of daffy 
activity (section II of the NHP) are shown in Fig. 2. 
There were significant differences between the two 
groups in social ife, home life, and holidays. Activities 
around the home just failed to reach statistical 
significance. Taking all aspects of daily life together, 
however, there was a significant difference between 
the claudicants and controls (0.05 > p > 0.02, Chi- 
square test). 
Discussion 
Most measures of treatment outcome have until 
recently been based on technical success, patency 
rates, and safety parameters, 16 and in patients with IC 
have considered changes in walking distance or other 
objective measurements such as ankle-brachial pres- 
sure index. The limitation in independence and 
mobilit)~ however, may have profound effects on life 
style. 7 It has been suggested therefore that the tradi- 
tional efficacy/safety methods of assessing outcome 
should be extended to include quality of life as a third 
parameter) 8'19 This will also allow better assessment 
of the cost-effectiveness of various treatment modali- 
ties and help optimise utilisation of health-care 
resources. 
Clinicians are poor at assessing the impact of an 
illness on the patients' perception of quality of life 1°'11 
and many instruments have been designed for meas- 
uring it. 2° There are two basic types, disease specific 
and generic. The NHP is an example of a generic 
instrument designed to be applicable to a wide range 
of health problems. 21 Such a broad approach ma)~ 
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however, reduce the sensitivity of this tool to the 
effects of various treatment modalities. 22The NHP has 
been well validated for self-administration. 14 
The conservative approach to the treatment of 
patients with IC has been based on the perception, by 
clinicians, that the discomfort and restriction in 
lifestyle caused by the condition is generally not 
severe enough to justify the risks of surgical inter- 
vention. 2 The introduction ofPTA has, however, led to 
controversy about its exact role in the treatment of 
patients with IC, up to 40% of whom have an arterial 
lesion amenable to treatment with this modality. 4 
Looking at traditional outcome parameters of ankle- 
brachial pressure index and walking distance it has 
been suggested that an organised exercise programme 
is better than PTAf The introduction of either treat- 
ment would have major implications in terms of 
hospital facilities and costs. 
Before one can determine the impact any treatment 
will have on the quality of life in patients with IC, it is 
important to assess the actual degree of the problem. 
To this aim we applied the NHP to a group of 
claudicants and comparable controls. Previous tudies 
looking at this have not concentrated on claudicants 
alone12or have used inappropriate controls. 13 In their 
study Hunt et al. 12 included patients who had under- 
gone treatment for vascular disease or had been 
referred for surgical treatment. This would suggest a
heterogeneous group with varying degrees of disease 
severity. We have shown that a surprisingly high 
number of problems are experienced by patients with 
stable IC compared to controls who have undergone a 
similar sequence of referral by General Practitioners 
and review in surgical clinics, unlike the controls used 
by Arfvidsson et alJ 3 
We excluded nine out of 72 controls complaining of 
pain in the legs on walking as many patients with 
symptoms of intermittent claudication do not consult 
their doctor. In a study from Oxford, 23 only 50% of 
those with symptoms of intermittent claudication 
(determined by questionnaire) consulted a doctor, and 
this figure was only 10% in a study from London. 24 It 
is unlikely that all of these suffered from IC as this 
would give a prevalence of 12.5% which is excessive 
for this age group. It is more likel3~ therefore, that 
some of these patients had musculoskeletal conditions 
causing exercise-induced l g pain. 
Section II of the NHP is designed to assess the 
aspects of daily life which are being affected by 
perceived health problems. Although there is a sig- 
nificant difference between claudicants and controls 
for all the aspects of this section taken together, 
individually there was no difference for job of work, 
looking after the home, sex life, and interests and 
hobbies. Considering job of work most of the subjects 
are of retirement age (90% had retired), or will have 
taken early retirement for health reasons, and will 
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Fig. 1. Graph showing mean scores in Section I of the NHP for claudicants and controls. There are significant differences between the two 
groups for energ~ pain, emotional reaction, sleep, and physical mobility (p values determined using Mann-Whitney Test). ([3) daudicants; 
(ll) controls. 
Eur J Vasc Endovasc Surg Vol 11, January 1996 
68 H. $. Khaira et aL 
Table 2. Correlation coefficients for the components of Section I of 
the NHP for patients with intermittent claudication 
Energy Pa in  Emotion Sleep Social 
isolation 
Pain 0.572** 
Emotion 0.719 ~ 0.445** 
Sleep 0.656** 0.613"* 0.461"* 
Socialisolation 0.379* 0.162 0.440'* 0.275* 
Mobility 0.720" 0.637** 0.501"* 0.651"* 0.406"* 
*p<O.05; p<O.O02 (Spearman s Rank Correlation Test). 
usefulness of the question which refers to paid 
employment. The lack of a difference in the other areas 
of daily living may be explained by the presence of 
other illnesses in the two groups. If patients with these 
additional ailments are removed from the data analy- 
sis we are left with 41 patients in the claudicant group 
and 39 in the control group. Both groups are still age 
and sex matched. Now we find significant differences 
in all areas of section II except work and sex life. 
Section I of the profile shows no difference between 
patients and controls in feelings of social isolation. 
However, this is not reflected in section II where there 
is an obvious difference in effect on social life (e.g. 
going out to see friends). There are a number of 
possible explanations: (1) all the factors in section I
will have an effect on the responses to section II and 
thus one cannot compare feelings of social isolation 
from section I to the overall effect on social inter- 
actions; (2) this may reflect a limitation of the profile as 
a large number of zero scores in section I, as indicated 
by the very low mean scores for Social Isolation, 
results in highly skewed and, therefore, unreliable 
data; and (3) there may be interference from additional 
illnesses - -  removing those patients with additional 
illnesses results in a greater difference between 
patients and controls in feelings of social isolation but 
just fails to reach statistical significance (p = 0.06). 
There are significant correlations between the com- 
ponents of section I of the NHP, suggesting an 
interrelationship amongst the various factors. This has 
been shown previously when the NHP was used in a 
group with limited mobility (amputees). 25 Using a 
logistic regression analysis model with stepwise lim- 
ination, physical mobility was found to be the only 
factor with a significant predictive effect - -  again 
• similar to previous reports using the NHP. ~5 This 
suggests, therefore, that restriction in mobility is the 
underlying cause of the differences between claudi- 
cants and controls. 
Thus, we have shown with this profile that patients 
with IC have significantly higher scores in the areas of 
perceived health problems compared to controls and 
that these have significant impact on activities of daily 
living. Because of the cost and resource implications of 
introducing measures uch as surger)5 PTA, or struc- 
tured exercise classes to the treatment of the vast 
numbers of patients with IC, prospective controlled 
trials are necessary to compare various treatments 
using instruments to measure quality of life in 
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Fig. 2. Graph showing the percentage positive responses for aspects of daily life in section II of the NHP. There are significant differences 
for social life, home life, and holidays (p values determined using Chi-square Test). ([~) claudicants; (ll) controls. 
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